ProfileGDS4718 / 1563468_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 23% 17% 23% 17% 21% 49% 38% 15% 14% 13% 22% 19% 22% 41% 38% 26% 13% 50% 47% 53% 14% 24% 21% 13% 19% 29% 22% 39% 16% 35% 37% 55% 18% 17% 34% 47% 24% 16% 13% 25% 24% 38% 28% 33% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.2582723
GSM549102patient 115, normal, homogenized [OPG study]4.0600717
GSM549104patient 119, normal, homogenized [OPG study]4.2381823
GSM549108patient 138, normal, homogenized [OPG study]4.0636617
GSM549119patient 077, normal, homogenized [OPG study]4.1712821
GSM549133patient 032, cancer, homogenized [OPG study]5.4010349
GSM549139patient 042, cancer, homogenized [OPG study]4.8600238
GSM549099patient 107, normal, homogenized [OPG study]3.9675515
GSM549109patient 139, normal, homogenized [OPG study]3.9412714
GSM549110patient 046, normal, homogenized [OPG study]3.9066813
GSM549114patient 063, normal, homogenized [OPG study]4.1797522
GSM549122patient 082, normal, homogenized [OPG study]4.1211619
GSM549134patient 033, cancer, homogenized [OPG study]4.2039322
GSM549136patient 036, cancer, homogenized [OPG study]4.9720441
GSM549140patient 044, cancer, homogenized [OPG study]4.8305638
GSM549111patient 047, normal, homogenized [OPG study]4.3706626
GSM549113patient 057, normal, homogenized [OPG study]3.8347913
GSM549132patient 031, cancer, homogenized [OPG study]5.4780950
GSM549137patient 038, cancer, homogenized [OPG study]5.3193447
GSM549142patient 047, cancer, homogenized [OPG study]5.8314853
GSM549100patient 110, normal, homogenized [OPG study]3.9358314
GSM549107patient 135, normal, homogenized [OPG study]4.2534324
GSM549115patient 068, normal, homogenized [OPG study]4.1359221
GSM549116patient 072, normal, homogenized [OPG study]3.8804913
GSM549120patient 078, normal, homogenized [OPG study]4.105519
GSM549131patient 030, cancer, homogenized [OPG study]4.4274429
GSM549118patient 074, normal, homogenized [OPG study]4.2381822
GSM549129patient 027, cancer, homogenized [OPG study]4.9360339
GSM549123patient 088, normal, homogenized [OPG study]3.9993116
GSM549124patient 006, cancer, homogenized [OPG study]4.8173235
GSM549126patient 015, cancer, homogenized [OPG study]4.8297937
GSM549128patient 025, cancer, homogenized [OPG study]5.8376955
GSM549103patient 117, normal, homogenized [OPG study]4.1212618
GSM549117patient 073, normal, homogenized [OPG study]4.0251617
GSM549138patient 041, cancer, homogenized [OPG study]4.7038834
GSM549141patient 045, cancer, homogenized [OPG study]5.2983447
GSM549130patient 028, cancer, homogenized [OPG study]4.316624
GSM549101patient 111, normal, homogenized [OPG study]3.98616
GSM549105patient 128, normal, homogenized [OPG study]3.8847813
GSM549106patient 134, normal, homogenized [OPG study]4.2798525
GSM549112patient 048, normal, homogenized [OPG study]4.298124
GSM549125patient 011, cancer, homogenized [OPG study]4.9090238
GSM549127patient 024, cancer, homogenized [OPG study]4.4454428
GSM549135patient 035, cancer, homogenized [OPG study]4.6210833